Coronavirus puts drug repurposing on the fast track

  title={Coronavirus puts drug repurposing on the fast track},
  author={Charlotte Harrison},
  journal={Nature Biotechnology},
  pages={379 - 381}
  • C. Harrison
  • Published 27 February 2020
  • Medicine
  • Nature Biotechnology
Existing antivirals and knowledge gained from the SARS and MERS outbreaks gain traction as the fastest route to fight the current coronavirus epidemic. Existing antivirals and knowledge gained from the SARS and MERS outbreaks gain traction as the fastest route to fight the current coronavirus epidemic. 

Tables and Topics from this paper

Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
In this manuscript we highlight consensus between the list of drugs currently in clinical trials to treat COVID-19, the worldwide pandemic caused by severe acute respiratory coronavirus 2
COVID-19 therapies and vaccine landscape
Within a few weeks of the novel coronavirus genome sequence being published, numerous therapies and vaccines have entered clinical trials with a few showing great promise in alleviating symptoms and
Drug repurposing in the era of COVID‐19: a call for leadership and government investment
The current COVID19 epidemic suggests that urgent investment in repurposed drugs is a necessary strategy and advises against using standard care for people with viral illnesses.
Immune response and possible therapeutics in COVID-19
This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.
The race against COVID-19
  • Medicine
    Nature Nanotechnology
  • 2020
The identification and isolation of individuals with COVID-19 can help to flatten the epidemic curve and win us time to wait for the vaccine development and production, and antiviral drug therapies.
An update on emerging therapeutics to combat COVID‐19
The CO VID‐19 pandemic has demanded effective therapeutic protocol from researchers and clinicians across the world; the clinician needs objective evidence‐based medication to treat COVID‐19.
COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks
The genome structure of SARS-CoV-2 and its role in the proteomic rational spread of different muted species and pathogenesis in infecting the host cells is discussed and current challenges involved in the drug development, bulk production of drug/vaccines and their storage requirements, logistical procedures and limitations related to dosage trials for larger population are concluded.
Repurposing anticancer drugs for the management of COVID-19
This Review discusses some repurposed anticancer drugs for the treatment of COVID-19 and under investigation in clinical trials or proposed for the clinical testing.
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
A critical view of ongoing drug repurposing efforts for COVID-19 is presented as well as discussing opportunities for development of new treatments based on current knowledge of the mechanism of infection and potential targets within.
Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox.
The epidemiological paradox between coronavirus disease 2019 (COVID-19) and malaria is discovered and the mechanism of action of some antimalarial drugs suggests their potential role in the chemoprophylaxis of the epidemic.